CLINICAL_TRIALS
trial_result
· 2009-09-11
Clinical Trial Update: Fesoterodine Flexible Dose Study [Phase 3]
Summary
Phase 3 study of fesoterodine with flexible dosing in adults with overactive bladder completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Overactive Bladder | Phase 3 | Status: COMPLETED | Results posted: 2009-09-11